All News

Online Misinformation on UTIs, ASB is Common and Dangerous: New Research
November 22, 2024

At least 1 accurate UTI symptom was found on most of the 331 websites reviewed, but nearly all (80%) included at least 1 inaccurate or misleading one.

Three-Quarters of US Adults Want to Be Asked About Mental Health in Primary Care Visits: New Survey
November 22, 2024

Approximately 70% of US adults surveyed hope their primary care clinician will ask about their mental health during an appointment, regardless of the presenting issue.

2025 GOLD Report on COPD Addresses Cardiovascular Risk in New Section: MeiLan Han, MD, MS, Highlights Rationale
November 22, 2024

Cardiovascular comorbidities in adults with COPD are linked to poor outcomes including reduced QoL, increased hospitalizations, and greater risk of mortality, Han explains.

US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose
November 22, 2024

Your daily dose of the clinical news you may have missed.

Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications
November 21, 2024

Michael Crotty, MD, an expert in obesity medicine, discusses GLP-1RAs in the context of weight loss, including the novel dual agonist survodutide.

FDA Clears Phase 2 Study of Cannabis for PTSD Treatment in Veterans
November 21, 2024

After a 3-year negotiation, the FDA has cleared a phase 2 clinical trial assessing the use of smoked cannabis for the treatment of PTSD symptoms in veterans.

Dupilumab, Ensifentrine Added to 2025 GOLD Guidelines for COPD: Expert Parses Recommendations
November 21, 2024

Professor MeiLan Han, MD, MS, details inclusion of the 2 new medications and how the additions reflect a focus on disease heterogeneity and precision medicine in in COPD.

Sharp Rise in Early-Onset Colorectal Cancer Mortality Among Young US Adults: Daily Dose
November 21, 2024

Your daily dose of the clinical news you may have missed.

More than Half of US Adults May Be Eligible for Semaglutide Therapy, Accordng to New Estimates
November 21, 2024

Millions of US adults could benefit from semaglutide treatment for diabetes, obesity, and/or CV disease but insurance isn't guaranteed and the drug is costly.

New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research
November 20, 2024

The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.